SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347 | -53.9% | 579 | 0.0% | 0.00% | – |
| Q2 2023 | $753 | -57.5% | 579 | -42.5% | 0.00% | – |
| Q1 2023 | $1,772 | -56.9% | 1,007 | -23.0% | 0.00% | – |
| Q4 2022 | $4,107 | -78.4% | 1,308 | -66.3% | 0.00% | – |
| Q3 2022 | $19,000 | +46.2% | 3,879 | +23.7% | 0.00% | – |
| Q2 2022 | $13,000 | -43.5% | 3,135 | -20.9% | 0.00% | – |
| Q1 2022 | $23,000 | +666.7% | 3,963 | +771.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 455 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 455 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 455 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -14.3% | 455 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | +75.0% | 455 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 455 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | -66.7% | 455 | -76.7% | 0.00% | – |
| Q1 2020 | $12,000 | +200.0% | 1,955 | +329.7% | 0.00% | – |
| Q4 2019 | $4,000 | 0.0% | 455 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 455 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 455 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 455 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -37.5% | 455 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | +33.3% | 455 | 0.0% | 0.00% | – |
| Q2 2018 | $6,000 | -33.3% | 455 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | +200.0% | 455 | +5.3% | 0.00% | – |
| Q2 2016 | $3,000 | 0.0% | 432 | -3.8% | 0.00% | – |
| Q1 2016 | $3,000 | -25.0% | 449 | +3.7% | 0.00% | – |
| Q4 2015 | $4,000 | +100.0% | 433 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -98.8% | 433 | -97.0% | 0.00% | – |
| Q2 2015 | $162,000 | -28.3% | 14,600 | +1.9% | 0.00% | – |
| Q1 2015 | $226,000 | -45.3% | 14,328 | -47.4% | 0.00% | – |
| Q4 2014 | $413,000 | +40.5% | 27,228 | 0.0% | 0.00% | – |
| Q3 2014 | $294,000 | +9700.0% | 27,228 | +11842.1% | 0.00% | – |
| Q2 2014 | $3,000 | -25.0% | 228 | +15.2% | 0.00% | – |
| Q1 2014 | $4,000 | -99.3% | 198 | -99.5% | 0.00% | -100.0% |
| Q4 2013 | $562,000 | +32.5% | 40,500 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $424,000 | – | 40,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |